ABINGDON HEALTH PLC (ABDX) — Interim results for the six months ended 31 December 2024

Investor webinar replay

Replay transcript excerpt

Good morning, and welcome to the ABDON HEALTH PLC interim results investor presentation. Throughout this recorded presentation, investors will be in listen only mode. Questions are encouraged, they can be submitted at any time by the q and a tab situated in the right corner of your screen. Just simply type in your questions and press send. The company may not be in a position to answer every question received in the meeting itself. However, the company can review all the questions submitted today and publish responses where it is appropriate to do so. Before we begin, I'd like to submit the following poll. I'd now like to hand you over to chairman, Hand. Good morning to you, sir. Good morning, and good morning, everyone, and thanks for joining this presentation of ABDON HEALTH's interim results to for the period to December 24. I'm Chris Hand, and I'm one of the founders of ABDON HEALTH. I'm the executive chairman of the company, and a bit of background on me, and I have thirty years experience in the medical diagnostics industry, particularly in the developments and commercialization of rapid diagnostic tests such as those that we develop and manufacture at ABDON HEALTH. Previously, I co founded another natural flow based testing company, Cozart PLC, which we sold to Concartino back in 2007. And then my my background, as I said, is in medical diagnostics and rapid testing. I'm joined today by Tom Hayes, our our new CFO, and I'll ask Tom to introduce himself. Yes. Thanks, Chris. So I'm Tom Hayes. Joined ABDON HEALTH as CFO in January 25. So I'm a chartered accountant by background. I previously spent ten years as FD of another aim listed group, Northern Bear PLC. And prior to that, my my experience has been in large accountancy firms and advisory roles, mostly in cor...